- November 21, 2019
- Category: Healthcare and LifeSciences, Medical Diagnostics
Global Molecular Diagnostics Market Size study, by Product & Services (Reagents & Kits, Instruments, Services & Software), by Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Others), by Application (Infectious Diseases, Oncology, Genetic Tests, Others), by End-User (Hospital & Academic Laboratories, Reference Laboratories, Others) and Regional Forecasts 2020-2026
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion) 1.2.1. Molecular Diagnostics Market, by Region, 2018-2026 (USD Billion) 1.2.2. Molecular Diagnostics Market, by Product & Services, 2018-2026 (USD Billion) 1.2.3. Molecular Diagnostics Market, by Technology, 2018-2026 (USD Billion) 1.2.4. Molecular Diagnostics Market, by Application, 2018-2026 (USD Billion) 1.2.5. Molecular Diagnostics Market, by End-User, 2018-2026 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Molecular Diagnostics Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Molecular Diagnostics Market Dynamics 3.1. Molecular Diagnostics Market Impact Analysis (2018-2026) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Molecular Diagnostics Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Molecular Diagnostics Market, by Product & Services 5.1. Market Snapshot 5.2. Global Molecular Diagnostics Market by Product & Services, Performance - Potential Analysis 5.3. Global Molecular Diagnostics Market Estimates & Forecasts by Product & Services 2016-2026 (USD Billion) 5.4. Molecular Diagnostics Market, Sub Segment Analysis 5.4.1. Reagents & Kits 5.4.2. Instruments 5.4.3. Services & Software Chapter 6. Global Molecular Diagnostics Market, by Technology 6.1. Market Snapshot 6.2. Global Molecular Diagnostics Market by Technology, Performance - Potential Analysis 6.3. Global Molecular Diagnostics Market Estimates & Forecasts by Technology 2016-2026 (USD Billion) 6.4. Molecular Diagnostics Market, Sub Segment Analysis 6.4.1. Polymerase Chain Reaction (PCR) 6.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 6.4.3. DNA Sequencing & Next-Generation Sequencing (NGS) 6.4.4. DNA Microarray 6.4.5. Others Chapter 7. Global Molecular Diagnostics Market, by Application 7.1. Market Snapshot 7.2. Global Molecular Diagnostics Market by Application, Performance - Potential Analysis 7.3. Global Molecular Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion) 7.4. Molecular Diagnostics Market, Sub Segment Analysis 7.4.1. Infectious Diseases 7.4.2. Oncology 7.4.3. Genetic Tests 7.4.4. Others Chapter 8. Global Molecular Diagnostics Market, by End-User 8.1. Market Snapshot 8.2. Global Molecular Diagnostics Market by End-User, Performance - Potential Analysis 8.3. Global Molecular Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion) 8.4. Molecular Diagnostics Market, Sub Segment Analysis 8.4.1. Hospital & Academic Laboratories 8.4.2. Reference Laboratories 8.4.3. Others Chapter 9. Global Molecular Diagnostics Market, Regional Analysis 9.1. Molecular Diagnostics Market, Regional Market Snapshot 9.2. North America Molecular Diagnostics Market 9.2.1. U.S. Molecular Diagnostics Market 184.108.40.206. Product & Services breakdown estimates & forecasts, 2016-2026 220.127.116.11. Technology breakdown estimates & forecasts, 2016-2026 18.104.22.168. Application breakdown estimates & forecasts, 2016-2026 22.214.171.124. End-User breakdown estimates & forecasts, 2016-2026 9.2.2. Canada Molecular Diagnostics Market 9.3. Europe Molecular Diagnostics Market Snapshot 9.3.1. U.K. Molecular Diagnostics Market 9.3.2. Germany Molecular Diagnostics Market 9.3.3. Rest of Europe Molecular Diagnostics Market 9.4. Asia-Pacific Molecular Diagnostics Market Snapshot 9.4.1. China Molecular Diagnostics Market 9.4.2. India Molecular Diagnostics Market 9.4.3. Japan Molecular Diagnostics Market 9.4.4. Rest of Asia Pacific Molecular Diagnostics Market 9.5. Latin America Molecular Diagnostics Market Snapshot 9.5.1. Brazil Molecular Diagnostics Market 9.5.2. Mexico Molecular Diagnostics Market 9.6. Rest of The World Molecular Diagnostics Market Chapter 10. Competitive Intelligence 10.1. Top Market Strategies 10.2. Company Profiles 10.2.1. Abbott Laboratories 10.2.1.1. Key Information 10.2.1.2. Overview 10.2.1.3. Financial (Subject to Data Availability) 10.2.1.4. Product Summary 10.2.1.5. Recent Developments 10.2.2. Becton, Dickinson and Company 10.2.3. Agilent Technologies, Inc. 10.2.4. Biomérieux Sa 10.2.5. Danaher Corporation 10.2.6. DiaSorin 10.2.7. Grifols, S.A. 10.2.8. Hologic, Inc. 10.2.9. Illumina, Inc. 10.2.10. Thermo Fisher Scientific, Inc. Chapter 11. Research Process 11.1. Research Process 11.1.1. Data Mining 11.1.2. Analysis 11.1.3. Market Estimation 11.1.4. Validation 11.1.5. Publishing 11.2. Research Attributes 11.3. Research Assumption
Global Molecular Diagnostics Market is valued approximately at USD 8.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2020-2026. The molecular diagnostics is a technique used to examine biological markers involved in a broad range of human ailments. Molecular diagnostic tests are the basic part of a successful healthcare system. Molecular diagnostic tests deliver vital information that helps healthcare patients and providers to make accurate medical decisions for better outcome of a medical procedure. This technique often provides quantitative measurements that inform each stage of care and facilitate successful management of health circumstances. Molecular diagnostics tools enhance the clinical setting, offer sensitive and rapid approaches for the identification and monitor various infectious diseases such as types of cancer, and other chronic diseases. Thus, rise in the incidences of infectious diseases and cancer owing to growing elderly population, along with the growing awareness and acceptance of personalized medicine and companion diagnostics are the few factors responsible for high CAGR of the market over the forecast period. According to the International Agency for Research on Cancer (IARC), in 2018, there were around 17.0 million new cancer cases and 9.5 million cancer deaths registered throughout the world. Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This, in turn, is expected to accelerate the demand for Molecular Diagnostics, thus contributing to the growth of the global market. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Molecular Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer and infectious diseases, presence of a well-developed healthcare infrastructure and rapid rise in clinical laboratories across the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increased healthcare spending by a larger population base and growing aging population in the countries like China and India.
Major market player included in this report are:
Becton, Dickinson and Company
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Services:
Reagents & Kits
Services & Software
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing & Next-Generation Sequencing (NGS)
Hospital & Academic Laboratories
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Molecular Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers